CENTRE OSCAR LAMBRET
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 251
- Market Cap
- -
Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: Blood samplingProcedure: BIOPSYProcedure: SURGERY
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 66
- Registration Number
- NCT00911911
- Locations
- 🇫🇷
Intercommunal Hospital, Annemasse, France
🇫🇷Hopital Saint Vincent, Lille, France
🇫🇷Centre Oscar Lambret, Lille, France
Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors
Phase 2
Completed
- Conditions
- Metastatic Colorectal CancerNon-Small-Cell Lung Carcinoma
- Interventions
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 30
- Registration Number
- NCT00910676
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
🇫🇷Centre Hospitalier Regional, Lille, France
🇫🇷Centre Hospitalier Régional, Lille, France
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer
Phase 4
Completed
- Conditions
- Esophageal Cancer
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2012-01-02
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 50
- Registration Number
- NCT00911092
- Locations
- 🇫🇷
Centre Paul Papin, Angers, France
🇫🇷Centre François BACLESSE, Caen, France
🇫🇷Centre Oscar Lambret, Lille, France
Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer
Phase 3
Completed
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 89
- Registration Number
- NCT00905047
- Locations
- 🇫🇷
Centre Hospitalier Regional, Lille, France
🇫🇷Centre Hospitalier de CHOLET, Cholet, France
🇫🇷Centre Hospitalier, Valenciennes, France
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
Phase 2
- Conditions
- Cervical CancerEndometrial CancerFallopian Tube CancerOvarian CancerSarcomaVaginal CancerVulvar Cancer
- Interventions
- Procedure: standard follow-up careDietary Supplement: therapeutic nutritional supplementation
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2009-07-29
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 120
- Registration Number
- NCT00905658
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
Phase 4
Completed
- Conditions
- Breast Cancer
- Interventions
- Other: FDG-PET
- First Posted Date
- 2009-05-19
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 63
- Registration Number
- NCT00904410
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
Terminated
- Conditions
- Anal CancerAnxiety DisorderBreast CancerDepressionEsophageal CancerGallbladder CancerGastric CancerKidney CancerLiver CancerLung Cancer
- First Posted Date
- 2009-05-11
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 200
- Registration Number
- NCT00896467
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
🇫🇷Laboratoire URECA, Villeneuve d'Ascq, France
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 44
- Registration Number
- NCT00893061
- Locations
- 🇫🇷
Centre Paul Strauss, Strasbourg, France
🇫🇷Centre Eugene Marquis, Rennes, France
🇫🇷Centre Oscar Lambret, Lille, France
Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery
Phase 2
- Conditions
- Sarcoma
- First Posted Date
- 2009-04-03
- Last Posted Date
- 2009-12-24
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 96
- Registration Number
- NCT00874874
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
Not Applicable
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2008-12-16
- Last Posted Date
- 2011-05-13
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 40
- Registration Number
- NCT00809016
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
© Copyright 2025. All Rights Reserved by MedPath